Cassava Sciences Inc (NASDAQ:SAVA)

45.78
Delayed Data
As of Jan 14
 +0.09 / +0.20%
Today’s Change
9.98
Today|||52-Week Range
146.16
+4.76%
Year-to-Date
IVC Wealth Advisors LLC Buys West Pharmaceutical Services Inc, iShares J.P. ...
Jan 13 / GuruFocus News - Paid Partner Content
Where Will Cassava Sciences Be in 1 Year?
Jan 07 / MotleyFool.com - Paid Partner Content
Biogen (BIIB) Down on Medicare Draft Ruling for Alzheimer's Drugs
Jan 12 / Zacks.com - Paid Partner Content
3 Healthcare Stocks That Could Rocket Higher in 2022
Jan 04 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close45.69
Today’s open45.02
Day’s range44.40 - 46.59
Volume37,595
Average volume (3 months)5,411,002
Market cap$1.8B
Data as of 4:46pm ET, 01/14/2022

Growth & Valuation

Earnings growth (last year)+8.80%
Earnings growth (this year)-232.29%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book17.49

Competitors

 Today’s
change
Today’s
% change
PRTAProthena Corporation...+2.19+5.88%
ALLOAllogene Therapeutic...+1.32+11.04%
----
PTGXProtagonist Therapeu...+1.21+3.48%
Data as of 4:00pm ET, 01/14/2022

Financials

Next reporting dateMarch 30, 2022
EPS forecast (this quarter)-$0.33
Annual revenue (last year)$0.00
Annual profit (last year)-$6.3M
Net profit margin--

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
No executives to display
Corporate headquarters
Austin, Texas

Forecasts